Discovery - Top 10
By people
- 593 yuen, m
- 593 yuen, man-fung
- 593 yuen, mf
- 593 yuen, richard man fung
- 593 yuen, rmf
- 593 袁孟峰
- 520 lam, k
- 520 lam, karen
- 520 lam, karen siu ling
- 520 lam, ksl
HKU Organizations
- 6276 li ka shing faculty of medicine
- 5763 department of medicine
- 531 li ka shing faculty of medicine
- 463 department of pharmacology and ph...
- 278 department of surgery
- 261 president's office
- 248 school of clinical medicine
- 219 school of biomedical sciences
- 194 department of family medicine and...
- 175 department of pathology
Browse
Collection's Items (Sorted by Submit Date in Descending order): 921 to 940 of 6385
Title | Author(s) | Issue Date | |
---|---|---|---|
Diseaese Modifying Drugs (DMD) for Mutliple Sclerosis (MS): Optimization of Benefits and Personalization Proceeding/Conference:Annual Scientific Meeting of the Macao Neuro-medical Society 2019 | 2019 | ||
Phase 1 oncology in Hong Kong Proceeding/Conference:NECTA Symposium 2019 | 2019 | ||
Novel treatment for HER2-positive breast cancer Proceeding/Conference:Best of SABCS 2018 Symposium: Review Hong Kong 2018 | 2019 | ||
The Evolving Landscape of Immunotherapy-Based Combinations in Hepatocellular Carcinoma - What Should We Be Considering Proceeding/Conference:Best of ASCO 2019 Meeting, Taipei Taiwan | 2019 | ||
Immunotherapy and Combinations in the Management of Advanced HCC Proceeding/Conference:The 10th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2019) | 2019 | ||
Hong Kong Liver Cancer Staging Proceeding/Conference:The 10th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2019) | 2019 | ||
Systemic Treatment in HCC: Is There Light at the End of the Tunnel? Proceeding/Conference:Asia-Pacific Gastroenterology Cancer Summit (APGCS) 2014 | 2014 | ||
Does CONCUR CORRECT-ly concur in treatment settings of mCRC – The Asian Perspective Proceeding/Conference:Asia-Pacific Gastroenterology Cancer Summit (APGCS) 2014 | 2014 | ||
45 Years Old Gentleman with Pancreatic Neuroendocrine Tumour: Advances in the Therapeutic Options Proceeding/Conference:Asia-Pacific Gastroenterology Cancer Summit 2013 | 2013 | ||
Novel Targeted Therapies in the Management of Hepatocellular Carcinoma Proceeding/Conference:Asia-Pacific Gastroenterology Cancer Summit 2013 | 2013 | ||
Portending the future: How will a positive 1st line trial with check-point inhibitors in HCC change the treatment paradigm in HCC Proceeding/Conference:6th Asia-Pacific Gastroenterology Cancer Summit (APGCS) 2019 | 2019 | ||
Immunotherapy in Hepatocellular Carcinoma: an update Proceeding/Conference:3rd Singapore Liver Cancer Consortium (SLCC) Symposiium, 2019 | 2019 | ||
Neuroendocrine Tumor Treatment Development in Asia Proceeding/Conference:Asian Neuroendocrine Tumor Expert Meeting (ANEM 2019) | 2019 | ||
Immune Checkpoint Inhibitor for Hepatocellular Carcinoma Proceeding/Conference:Multi-specialty Medical Mega Conference 2019 (M3C 9.0 Conference), Hong Kong | 2019 | ||
Disruptions in Medicine: Impact on Specialist Training Proceeding/Conference:Hong Kong Hospital Authority Convention 2019 | 2019 | ||
Taking a Leap Forward: What is the Latest Evidence of Systemic Therapy in Advanced Hepatocellular Carcinoma? Proceeding/Conference:26th Annual Scientific Meeting of Hong Kong College of Radiologists, 2018 | 2018 | ||
Dysregulated Inflammasome Response in Systemic Lupus Erythematosus Proceeding/Conference:Next Generation Researchers Meeting (NGRM) of 2019 East Asian Group of Rheumatology | 2019 | ||
Detection of Covalently Closed Circular DNA and HBV DNA Integration in HCC Patients with Occult Hepatitis B Proceeding/Conference:Hepatology | 2019 | ||
2019 | |||
Trends in Liver Transplantation for Chronic Hepatitis B in the Era of Highly Potent Antiviral Therapies Proceeding/Conference:Hepatology | 2019 |
Collection's Items (Sorted by Submit Date in Descending order): 921 to 940 of 6385